News about "osteoarthritis treatment"

Ono Pharmaceutical Enters into Definitive Agreement with Seikagaku for Co-development and Marketing Collaboration on Gel-One in Japan

Ono Pharmaceutical Enters into Definitive Agreement with Seikagaku for Co-development and Marketing Collaboration on Gel-One in Japan

Ono Pharmaceutical has signed a definitive agreement with Seikagaku Corporation for the co-development and exclusive marketing of Gel-One for osteoarthritis treatment in Japan.

Osteoarthritis Treatment | 11/08/2025 | By Mrinmoy Dey 173


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members